30 participants
Evaluation of a Cancer Lysate Vaccine and Montanide (Registered Trademark) ISA-51 VG With or Without the IL-15 Super-Agonist N-803 as Adjuvant Therapy for PD-L1 Negative Non-Small Cell Lung Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-12
- Start Date:
- 2026-08-17
- Completion:
- 2033-12-30
Conditions
- Non-Small Cell Lung Cancer
- Non-Small Cell Lung Carcinoma
- Carcinoma, Non-Small-Cell Lung
- Carcinomas
Interventions
- BIOLOGICAL
- DRUG
- DEVICE
No Results Yet